1[1]SCHLEICHER E,NERLICH A.The role of hyperglycemia in the development of diabetic complications[J].Horm Metab Res,1996,28(8):367-373.
2[2]CHIARELLI F,TROTTA D,VERROTTI A.Kidney involvement and disease in patients with diabetes[J].Panminerva Med,2003,45(1):23-41.
3[3]YAMAGISHI S,INAGAKI Y,OKAMNOTO T,et al.Advanced glylation end products inhibit de novo protein synthesis and induce TGF-beta over expression in proximal tubular cells[J].Kidney Int,2003,63(2):464-473.
4[4]LI J H,HUANG X R,ZHU H J,et al.Advanced glycation end products activate smad signaling via TGF-beta-dependent and -independent mechanisms: implications for diabetic renal and vascular disease[J].FASEB J,2004,18(1):176-178.
5[5]BIERHAUS A,HOFMANN M A,ZIEGLER R,et al.AGEs and their interaction with AGE receptors in vascular disease and diabetes mellitus.PartⅠ.The AGE concept[J].Cardiovasc Res,1998,37(3):586-600.
6[6]BIERHAUS A,CHEVION A,CHEVION M,et al.Advanced glycation end product(AGEs) induced activation of NFκB is supressed by α-lipoic acid in culture endothelial cells[J].Diabetes,1997,46(9):1481-1490.
7[7]RENARD C,CHAPPEY O,WAUTIER M P,et al.Recombinant advanced-glycation end product receptor pharmacokinerics in normal and diabetic rats[J].Mol Pharmal,1997,52(1):54-62.
8[8]PARK J Y,HAS W,KING G L.The role of protein kinase C activation in the pathogenesis of diabetic vasular complications[J].Perit Dial Int,1999,19(suppl2):222-227.
2Ha H,Lee H B.Oxidative stress in diabetic nephropathy:basic and clinical information[J].Curr Diab Rep,2001,1(3):282-287.
3Mason R M,Wahab N A.Extracellar matrix metabolism in diabetic nephropathy[J].J Am Soc Nephrol,2003,14(5):1358-1373.
4Chiarelli F,Trotta D,Verrotti A.Kidney involvement and disease in patients with diabetes[J].Panminerva Med,2003,45(1):23-41.
5Yamagishi S,Inagaki Y,Okamnoto T,et al.Advanced glylation end products inhibit de novo protein synthesis and induce TGF-beta over expression in proximal tubular cells[J].Kidney Int,2003,63(2):464-473.
6Li J H,Huang X R,Zhu H J,et al.Advanced glycation end products activate Smad signaling via TGF-beta-dependent and -independent mechanisms:implications for diabetic renal and vascular disease[J].FASEB J,2004,18(1):176-178.
8Henry Krum Markus Schlaich Paul Sobotka Ingrid Scheffers Abraham A.Kroon Peter W.de Leeuw 童保文 林志鸿 谢良地.以手术和器械装置为基础的难治性高血压的治疗新策略[J].中华高血压杂志,2012,20(1):86-90.
